Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow continuous subcutaneous flumazenil infusion for benzodiazepine dependence: a pilot study
2014-000420-15Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mefenorex in benzodiazepine dependence and barbiturate abuse, sponsored by Radboud University Medical Center. Started Oct 2015; status: completed.
02
Drugs
mefenorex
03
Conditions
benzodiazepine dependencebarbiturate abuse
Beyond the preview
Go deeper on 2014-000420-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000420-15.